Keywords: roche/genentech, avastin, shows, efficacy, third, cancer, breast

Roche/Genentech's Avastin shows efficacy in third cancer, breast, in NCI trial

Article | 25 April 2005

Print This

An interim analysis of a Phase III study of Swiss drugmaker Roche and its US affiliate Genentech's cancer drug Avastin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in